LATS2 overexpression and the activation of DRP1-related mitochondrial division via Wnt/β-catenin could open promising strategies to treat hepatocellular cancer by inducing cell viability downregulation, mitochondrial dysfunction, energy depletion, and apoptosis activation on liver cancer cells [243]. This evidence concerns the gene LATS2 and liver cancer.